mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |